{"id":"NCT01893905","sponsor":"Tedec-Meiji Farma, S.A.","briefTitle":"Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis","officialTitle":"Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondroitin Sulfate and Glucosamine Sulfate in Combination Versus Placebo in Patients With Osteoarthritis of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2013-07-09","resultsPosted":"2017-08-04","lastUpdate":"2017-08-04"},"enrollment":158,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Knee Osteoarthritis"],"interventions":[{"type":"DRUG","name":"CS+SG","otherNames":["Chondroitin sulfate+glucosamine sulfate"]},{"type":"DRUG","name":"Placebo","otherNames":["Placebo chondroitin sulfate+glucosamine sulfate"]}],"arms":[{"label":"CS+SG","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main objective is to assess the efficacy of a new formulation containing chondroitin sulfate and glucosamine sulfate (CS+GS) compared with placebo in patients with primary osteoarthritis of the knee.","primaryOutcome":{"measure":"Change in Pain According to VAS (0-100 mm)","timeFrame":"24 weeks","effectByArm":[{"arm":"CS+SG","deltaMin":-11.86,"sd":2.42},{"arm":"Placebo","deltaMin":-20.57,"sd":2.41}],"pValues":[{"comp":"OG001","p":"<0.0307"}]},"eligibility":{"minAge":"45 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":1,"countries":["Spain"]},"refs":{"pmids":["27477804"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":80},"commonTop":["Back pain","Pain in extremity","Nasopharyngitis","Neck pain","Flatulence"]}}